[Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
Yang
Dan-hong
DH
Department of Infectious Diseases, Zhejiang Provincial People's Hospital, Hangzhou 310014, China. ydh-11@163.com
Xie
Shi-feng
SF
Wang
Ying-min
YM
Zhao
Nian-feng
NF
Li
Min-wei
MW
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000821:virology*; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000627:therapeutic use*
D000998:Antiviral Agents; D004279:DNA, Viral; D063065:Organophosphonates; D019259:Lamivudine; D000225:Adenine; C106812:adefovir dipivoxil